Clinical Trial Update: RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial) [NA]

View source ↗

Summary

A completed clinical trial (RESTORE) evaluated resveratrol for improving outcomes in older adults with peripheral arterial disease, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Northwestern University | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED | Results posted: 2018-04-30